The Long Read: Innovation, Access & Affordability in the USA
A Tale of Two Americas The US stands as the biopharma innovation champion of the world, a global leader on nearly all R&D indices related to…
Tagged with Takeda
PharmaBoardroom’s Top Women Leaders 2020
While great strides in gender diversity has been made within healthcare boardrooms and leadership teams globally, as well as more generally across the…
Top 10 PharmaBoardroom Interviews of 2020
2020 was a challenging year globally, but one in which the importance of the healthcare and life sciences sector was underlined like never before.…
Rare Disease Strategies in the Booming US Market
Rare disease – defined in the US as a disease with a maximum patient population of 200,000 – is perhaps the most salient issue at the nexus of…
Takeda USA’s Ramona Sequeira Talks “Culture as Strategy”
After five years with Takeda heading up the Japan-headquartered pharma company’s US business, following the organization’s 2019 USD 62 billion…
What Three Pharma Leaders Want to Share About Switzerland
PharmaBoardroom highlights three of the most enterprising and dynamic pharma affiliate country managers working in Switzerland today and their…
Pierre Morneau – General Manager, Takeda Switzerland
Pierrre Morneau of Takeda Switzerland explains the therapeutic areas at the core of the company, equitable access, the Swiss framework for rare…
Ramona Sequeira – President, Takeda Pharmaceuticals USA;…
Takeda USA’s Ramona Sequeira outlines her expanded role as president of global portfolio commercialization, the crucial importance of investing in…
Thomas Willemsen – SVP APAC, Takeda
In an exclusive and wide-ranging interview, Takeda APAC SVP Thomas Willemsen outlines his strategy for bringing the company’s specialty pharma…
Japanese Pharma’s Skyrocketing US Footprint
Following PharmaBoardroom’s recent interview with Ivan Cheung, chairman of Eisai’s US affiliate and president of Eisai’s global neurology…
Korean Celltrion Makes First Big Global Move with Acquisition of…
Korean biosimilar firm Celltrion’s USD 266 million acquisition of Japanese outfit Takeda assets in the Asia-Pacific region marks a significant…
Top 10 Pharma Companies in Japan
Japan’s pharma market is one of the world’s biggest, with a value of around USD 95 billion, according to figures from the country’s…
